Broad coverage across barrier mechanisms
Sections 2–6 cover oxidative stress, inflammatory signaling, permeability, T-cell function, and autophagy, while Figure 1 places them in one mechanistic overview.
↳ Sections 2–6; Figure 1
Abstract
Nrf2 (NF-E2-related factor 2) is a master regulator of cellular oxidative levels against environmental stresses. Nrf2 induces the expression of metabolic detoxification and antioxidant enzymes to eliminate reactive oxygen species (ROS). The gastrointestinal tract is a key source of ROS. Intestinal barrier is critical to maintain the healthy steady state of the human gastrointestinal tract. Nrf2 has been shown to play important roles in maintaining the integrity of intestinal mucosal barrier. Here, we made a systematic review on the roles of Nrf2 in maintaining intestinal barrier, including the following: (1) NRF2 reduced intestinal mucosal injury by suppressing oxidative stress; (2) NRF2 decreased intestinal inflammation by inhibiting the inflammatory pathway; (3) NRF2 affected intestinal tight junction proteins and apoptosis of cells to regulate intestinal permeability; (4) NRF2 affected T cell differentiation and functions; (5) the crossregulation between the KEAP1-NRF2 pathway and autophagy controlled intestinal oxidative stress.
Key Claims
Primary findingSupported
NRF2 reduced intestinal mucosal injury by suppressing oxidative stress
consistent direction across multiple preclinical models, with little direct human or clinical evidence
Abstract claim 1; Section 2
SecondarySupported
NRF2 decreased intestinal inflammation by inhibiting the inflammatory pathway
preclinical findings support reduced inflammation, but direct pathway inhibition remains unresolved against ROS-mediated effects
Abstract claim 2; Section 3
SecondarySupported
NRF2 affected intestinal tight junction proteins and apoptosis of cells to regulate intestinal permeability
several animal models support directional effects, but evidence remains predominantly preclinical
Abstract claim 3; Section 4
SecondaryTentative
NRF2 affected T cell differentiation and functions
conflicting activator studies and cytokine-based inference do not establish a unified intestinal T-cell mechanism
Abstract claim 4; Section 5
SecondaryTentative
the crossregulation between the KEAP1-NRF2 pathway and autophagy controlled intestinal oxidative stress
mechanistic associations are summarized, while the crossregulation itself remains explicitly unresolved
Abstract claim 5; Section 6
Derived from the full evaluation — not a separate score.
Strengths · Limitations
Strengths
Multiple preclinical contexts summarized
Table 1 brings together colitis, burn, ischemia-reperfusion, sepsis, traumatic brain injury, and other models, showing that the reviewed relationship is not confined to one experiment type.
↳ Section 2; Table 1
Clear mechanism-based navigation
The article's principal sections correspond directly to its five stated claims, allowing readers to locate the supporting studies and acknowledged uncertainties efficiently.
↳ Abstract; Sections 2–6
Limitations
Systematic label lacks review methods
The Abstract describes a systematic review, but the paper reports no databases, search terms, eligibility criteria, selection procedure, or study-quality appraisal.
↳ Abstract; absence of a review-methods section throughout the full text
Evidence synthesis remains one-sided
Sections 2–6 predominantly assemble studies supporting protective NRF2 effects. Constitutive-activation harms and oncogenesis are mentioned only in the Conclusion and are not substantively integrated into the synthesis.
↳ Sections 2–7
Abstract overstates unresolved mechanisms
Claims about direct inflammatory inhibition, T-cell effects, and autophagy crossregulation are stated as findings in the Abstract, whereas Sections 3, 5, and 6 explicitly retain substantial uncertainty.
↳ Abstract claims 2, 4, and 5; Sections 3, 5, and 6
Nabu Commentary
Table 1 and Figure 1 make the review useful as an entry point to NRF2-related intestinal barrier mechanisms across several preclinical contexts. The score is constrained by the absence of any systematic source-selection method despite the Abstract's study-type label. Sections 3, 5, and 6 also qualify mechanisms that the Abstract presents more definitively. Finally, the Conclusion acknowledges constitutive-activation and oncogenesis risks without integrating them into its therapeutic interpretation.
Author Note / Field Feedback
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Dimension breakdown
Study Quality
Limited2.6
Contribution
2.6
The review consolidates oxidative stress, inflammation, permeability, T-cell, and autophagy mechanisms into one accessible account. Its advance remains limited because Sections 2–6 mostly restate individual studies without resolving their uncertainties or developing a new integrative framework.
Abstract; Sections 2–7; Figure 1
“more studies are needed to investigate this crossregulation”
Methodological Rigour
2.5
Mechanism-based sections, Table 1, and Figure 1 provide a followable structure and link claims to cited studies. Evidence selection is predominantly protective in direction, and no search, eligibility, selection, or appraisal method is reported despite the systematic-review label.
Abstract; Sections 2–6; Table 1; Figure 1
“Here, we made a systematic review”
Reporting
3.1
The five-section organization makes the argument easy to navigate, although awkward phrasing occasionally interrupts readability. More materially, definitive abstract claims about inflammation, T cells, and autophagy are not calibrated to the uncertainty stated in Sections 3, 5, and 6.
Abstract claims 2, 4, and 5; Sections 3, 5, and 6
“the exact mechanism remains largely unknown”
Positioning
2.8
The review engages 46 references across numerous experimental models and acknowledges uncertainty in several mechanisms. The conclusion mentions lethality and oncogenesis from constitutive pathway activation but does not trace those caveats through its intestinal therapeutic claim.
Sections 2–7; Table 1; Conclusion
“constitutive activation of Nrf2 in the upper digestive tract tissues can result in serious adverse effects”
Reliability
Caveats4 of 4 checks
Internal CoherenceNoted
The study-type label is inconsistent with the reported review process: the Abstract claims a systematic review, while the body supplies no systematic method and describes the work as a summary. Several abstract claims are also more definitive than the uncertainty acknowledged in Sections 3, 5, and 6.
Research ConductClean
The article reports no original experiment, so ethics approval, preregistration, and data or code availability are not applicable; no research-conduct problem was demonstrated in the supplied text.
Flags: 0 declared / 5 total
Reference IntegrityClean
46 of 46 checkable references verified
46 references in manuscript 1 reference confirmed by manual review
Post-Publication RecordClean
No retraction notice found in Retraction Watch.
Last checked: 19 Aug 2026
Sources: Retraction Watch ✓
Impact Potential
Low2.3
Relevance
2.5
NRF2 modulation is connected to existing drug-development activity, and the conclusion identifies CDDO-Me and dimethyl fumarate. The paper does not specify an intestinal patient population, stakeholder decision, or concrete use for this synthesis.
Section 7, Conclusion
“There are substantial interests in developing Nrf2 inducers for therapeutic use.”
Readiness
2.0
The evidence summarized is predominantly from knockout animals, disease models, and cultured cells, with limited human-tissue evidence. The review therefore remains at mechanistic characterization rather than clinical guidance or deployment readiness.
Sections 2–6; Table 1
“different mouse disease models”
Generalizability
2.4
Consistent directional findings across colitis, ischemia-reperfusion, sepsis, burn, and traumatic-brain-injury models support transferability within preclinical settings. Sparse human evidence and unresolved harmful boundary conditions limit transfer to clinical populations.
Section 2; Table 1; Section 7
“various experimental models”
Trajectory
2.5
The review connects several NRF2 mechanisms and repeatedly identifies unresolved questions that can motivate further research. Most recommendations remain generic calls for more studies rather than specific hypotheses, comparisons, or study designs.
Sections 3, 5, 6, and 7
“more studies are required to clarify”
AI-generated, human-governed. Something look off? Contact us to request a review.